Globus Medical Revenue 2010-2022 | GMED

Globus Medical annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Globus Medical revenue for the quarter ending September 30, 2022 was $0.254B, a 10.63% increase year-over-year.
  • Globus Medical revenue for the twelve months ending September 30, 2022 was $0.998B, a 6.04% increase year-over-year.
  • Globus Medical annual revenue for 2021 was $0.958B, a 21.43% increase from 2020.
  • Globus Medical annual revenue for 2020 was $0.789B, a 0.47% increase from 2019.
  • Globus Medical annual revenue for 2019 was $0.785B, a 10.15% increase from 2018.
Globus Medical Annual Revenue
(Millions of US $)
2021 $958
2020 $789
2019 $785
2018 $713
2017 $636
2016 $564
2015 $545
2014 $474
2013 $434
2012 $386
2011 $331
2010 $288
2009 $254
Globus Medical Quarterly Revenue
(Millions of US $)
2022-09-30 $254
2022-06-30 $264
2022-03-31 $231
2021-12-31 $250
2021-09-30 $230
2021-06-30 $251
2021-03-31 $227
2020-12-31 $233
2020-09-30 $216
2020-06-30 $149
2020-03-31 $191
2019-12-31 $212
2019-09-30 $196
2019-06-30 $195
2019-03-31 $183
2018-12-31 $196
2018-09-30 $169
2018-06-30 $173
2018-03-31 $174
2017-12-31 $176
2017-09-30 $152
2017-06-30 $152
2017-03-31 $156
2016-12-31 $152
2016-09-30 $136
2016-06-30 $137
2016-03-31 $139
2015-12-31 $143
2015-09-30 $137
2015-06-30 $134
2015-03-31 $132
2014-12-31 $129
2014-09-30 $118
2014-06-30 $114
2014-03-31 $114
2013-12-31 $115
2013-09-30 $107
2013-06-30 $107
2013-03-31 $105
2012-12-31 $101
2012-09-30 $95
2012-06-30 $96
2012-03-31 $95
2011-12-31 $88
2011-09-30 $84
2011-06-30 $81
2011-03-31 $78
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.103B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Edwards Lifesciences (EW) United States $46.932B 32.30
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00